DeFronzo R A, Binder C, Wahren J, Felig P, Ferrannini E, Faber O K
Acta Endocrinol (Copenh). 1981 Sep;98(1):81-6. doi: 10.1530/acta.0.0980081.
The ability of insulin to inhibit its own secretion was examined in 15 normal subjects given an intravenous infusion of insulin in a dose of 0.25, 0.50, 1.0, 5.0 or 10.0 mU/kg/min for two hours. Arterial plasma insulin concentration achieved during the infusion segregated into three levels of hyperinsulinaemia: 35 +/- 1 (mean +/- SEM), 87 +/- 15 and 828 +/- 210 muU/ml. Plasma glucose concentration was kept constant at the basal level by a variable glucose infusion. Fasting C-peptide (0.29 +/- 0.02 pmol/ml) fell significantly in all subjects during hyperinsulinaemia and reached a concentration of 0.19 +/- 0.03 pmol/ml at 60 min and 0.14 +/- 0.03 at 120 min after the start of the insulin infusion. The C-peptide response was not related to the infusion dose nor to the steady state plasma insulin concentration. It is concluded that (a) basal insulin secretion as evaluated from C-peptide measurements is inhibited by small (24 +/- 3 muU/ml) physiological elevations in plasma insulin concentration independent of changes in plasma glucose, and (b) supraphysiological or even pharmacological elevations in plasma insulin do not result in a further decrease in endogenous insulin secretion above that achieved with mild hyperinsulinaemia.
在15名正常受试者中进行了胰岛素抑制自身分泌能力的研究,这些受试者以0.25、0.50、1.0、5.0或10.0 mU/kg/分钟的剂量静脉输注胰岛素,持续两小时。输注过程中达到的动脉血浆胰岛素浓度分为三个高胰岛素血症水平:35±1(平均值±标准误)、87±15和828±210 μU/ml。通过可变葡萄糖输注将血浆葡萄糖浓度维持在基础水平。在高胰岛素血症期间,所有受试者的空腹C肽(0.29±0.02 pmol/ml)均显著下降,在胰岛素输注开始后60分钟时达到0.19±0.03 pmol/ml的浓度,120分钟时达到0.14±0.03 pmol/ml。C肽反应与输注剂量和稳态血浆胰岛素浓度均无关。得出的结论是:(a)从C肽测量评估的基础胰岛素分泌受到血浆胰岛素浓度小幅度(24±3 μU/ml)生理性升高的抑制,且与血浆葡萄糖变化无关;(b)血浆胰岛素的超生理甚至药理升高不会导致内源性胰岛素分泌比轻度高胰岛素血症时进一步降低。